18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization

By sjmartinez • November 22, 2022

Packard RRS, Votaw JR, Cooke CD, Van Train KF, Garcia EV, Maddahi J. 18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization. Eur Heart J Cardiovasc Imaging. 2022 Nov 17;23(12):1636-1644. doi: 10.1093/ehjci/jeab267. PMID: 34928321; PMCID: PMC9671402.

Tags: Cardiology/Epi, diagnostic performance, flurpiridaz, myocardial blood flow, perfusion, PET, Publications, segmental

Influenza vaccination in patients with heart failure: comprehensive review of evidence, challenges, and clinical implications

Khan A, Khan M, Hammadeh BM, Ishaq MU, Naveed H, Allana S, Fudim M, Mentz RJ, Fonarow GC, Biering-Sørensen T. Influenza vaccination in patients with[...]

Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update

Kobashigawa J, Zuckermann A, Potena L, Ardehali A, Berman M, Chang PP, Esmailian F, Farr M, Hall S, Hsich E, Khush K, Kittleson M, Leprince[...]

The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment

Watson KE, Fonarow GC. The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for[...]